Cultured AFB Antitubercular DST Rapid 19 Drugs Panel Test
Comprehensive Tuberculosis Drug Sensitivity Testing
The Cultured AFB Antitubercular DST Rapid 19 Drugs Panel Test represents a significant advancement in tuberculosis diagnostics, providing comprehensive drug sensitivity profiling for Mycobacterium tuberculosis complex. This sophisticated test is crucial in the global fight against drug-resistant tuberculosis, which has become an increasing public health concern worldwide.
What This Test Measures and Detects
This comprehensive panel evaluates the susceptibility of Mycobacterium tuberculosis complex to 19 different anti-tuberculosis medications, including:
- First-line drugs: Streptomycin, Isoniazid, Rifampicin, Ethambutol, Pyrazinamide
- Second-line drugs: Clofazimine, Ethionamide, Capreomycin, Kanamycin, Amikacin
- Fluoroquinolones: Ofloxacin, Levofloxacin, Moxifloxacin
- Other agents: PAS, Cycloserine, Linezolid, Rifabutin, Amoxyclav, Clarithromycin
The test utilizes automated fluorescent technology to rapidly determine which medications will be effective against the specific strain of tuberculosis bacteria isolated from the patient.
Who Should Consider This Test
This advanced drug sensitivity testing is recommended for individuals who:
- Have persistent tuberculosis symptoms despite ongoing treatment
- Show signs of treatment failure or relapse
- Have been exposed to drug-resistant TB strains
- Are from regions with high rates of drug-resistant tuberculosis
- Have HIV co-infection with tuberculosis
- Experience side effects from current TB medications
- Have previously failed TB treatment regimens
Key Benefits of the 19-Drug Panel Test
Choosing this comprehensive drug sensitivity panel offers numerous advantages:
- Comprehensive Coverage: Tests 19 different anti-TB drugs for complete resistance profiling
- Rapid Results: Provides critical information within 21 days using advanced technology
- Personalized Treatment: Enables physicians to create targeted, effective treatment plans
- Cost-Effective Care: Helps avoid expensive, ineffective medications and prolonged illness
- Public Health Impact: Contributes to controlling drug-resistant TB transmission
- Improved Outcomes: Increases treatment success rates and reduces complications
Understanding Your Test Results
Your test results will provide detailed information about which anti-tuberculosis medications are likely to be effective against your specific TB strain. The report will indicate:
- Susceptible drugs that should be effective in treatment
- Resistant drugs that should be avoided
- Intermediate sensitivity drugs that may require adjusted dosing
- Specific resistance patterns that help guide combination therapy
Your physician will use these results to design a personalized treatment regimen that maximizes effectiveness while minimizing side effects and treatment duration.
Test Pricing Information
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Cultured AFB Antitubercular DST Rapid 19 Drugs Panel Test | $750 USD | $1000 USD |
Nationwide Testing Availability
We have diagnostic centers conveniently located throughout the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our state-of-the-art facilities ensure consistent, high-quality testing results nationwide.
Take Control of Your Tuberculosis Treatment
Don’t let drug-resistant tuberculosis compromise your health and recovery. Our comprehensive 19-drug panel test provides the critical information needed to develop an effective, personalized treatment plan. With rapid turnaround times and advanced testing technology, you can get the answers you need to fight tuberculosis effectively.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your test or speak with our healthcare specialists. Take the first step toward effective tuberculosis treatment with comprehensive drug sensitivity testing.
